vs
Side-by-side financial comparison of CHICAGO RIVET & MACHINE CO (CVR) and NovaBay Pharmaceuticals, Inc. (NBY). Click either name above to swap in a different company.
CHICAGO RIVET & MACHINE CO is the larger business by last-quarter revenue ($6.0M vs $4.8M, roughly 1.3× NovaBay Pharmaceuticals, Inc.). CHICAGO RIVET & MACHINE CO runs the higher net margin — -19.3% vs -25.5%, a 6.2% gap on every dollar of revenue. On growth, NovaBay Pharmaceuticals, Inc. posted the faster year-over-year revenue change (126.1% vs 45.9%). CHICAGO RIVET & MACHINE CO produced more free cash flow last quarter ($24.3K vs $-1.7M). Over the past eight quarters, NovaBay Pharmaceuticals, Inc.'s revenue compounded faster (42.5% CAGR vs -12.7%).
Chicago Pneumatic, also known as "CP", is an industrial manufacturer providing power tools, air compressors, generators, light towers and hydraulic equipment. Products are sold in more than 150 countries through a worldwide distribution network. CP is active on markets such as tools for industrial production, vehicle service, maintenance repair operation for mining, construction, infrastructure equipment.
NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on products for eye care. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis. and NeutroPhase, used in treatment of Necrotizing Fasciitis
CVR vs NBY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2024
| Metric | | |
|---|---|---|
| Revenue | $6.0M | $4.8M |
| Net Profit | $-1.2M | $-1.2M |
| Gross Margin | 2.7% | 65.2% |
| Operating Margin | -15.3% | -37.2% |
| Net Margin | -19.3% | -25.5% |
| Revenue YoY | 45.9% | 126.1% |
| Net Profit YoY | 68.0% | 70.5% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $6.0M | — | ||
| Q3 25 | $7.4M | — | ||
| Q2 25 | $7.3M | — | ||
| Q1 25 | $7.2M | — | ||
| Q4 24 | $4.1M | $4.8M | ||
| Q3 24 | $7.0M | $0 | ||
| Q2 24 | $8.1M | $2.4M | ||
| Q1 24 | $7.9M | $2.6M |
| Q4 25 | $-1.2M | — | ||
| Q3 25 | $67.6K | — | ||
| Q2 25 | $-395.0K | — | ||
| Q1 25 | $401.0K | — | ||
| Q4 24 | $-3.6M | $-1.2M | ||
| Q3 24 | $-1.4M | $-1.2M | ||
| Q2 24 | $142.1K | $-1.6M | ||
| Q1 24 | $-698.0K | $-3.2M |
| Q4 25 | 2.7% | — | ||
| Q3 25 | 18.1% | — | ||
| Q2 25 | 13.4% | — | ||
| Q1 25 | 22.9% | — | ||
| Q4 24 | -43.7% | 65.2% | ||
| Q3 24 | 10.0% | — | ||
| Q2 24 | 17.6% | 66.3% | ||
| Q1 24 | 9.5% | 68.2% |
| Q4 25 | -15.3% | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | -5.7% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | -86.4% | -37.2% | ||
| Q3 24 | -11.8% | — | ||
| Q2 24 | 1.3% | -67.4% | ||
| Q1 24 | -11.5% | -87.1% |
| Q4 25 | -19.3% | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | -5.4% | — | ||
| Q1 25 | 5.5% | — | ||
| Q4 24 | -88.0% | -25.5% | ||
| Q3 24 | -20.8% | — | ||
| Q2 24 | 1.8% | -66.0% | ||
| Q1 24 | -8.9% | -122.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-1.92 | ||
| Q2 24 | — | $-1.37 | ||
| Q1 24 | — | $-29.95 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7M | $430.0K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $18.8M | $-129.0K |
| Total Assets | $23.3M | $3.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7M | — | ||
| Q3 25 | $1.7M | — | ||
| Q2 25 | $1.2M | — | ||
| Q1 25 | $765.6K | — | ||
| Q4 24 | $2.2M | $430.0K | ||
| Q3 24 | $2.2M | $776.0K | ||
| Q2 24 | $2.6M | $751.0K | ||
| Q1 24 | $2.7M | $1.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $18.8M | — | ||
| Q3 25 | $20.0M | — | ||
| Q2 25 | $20.0M | — | ||
| Q1 25 | $20.4M | — | ||
| Q4 24 | $20.0M | $-129.0K | ||
| Q3 24 | $23.7M | $1.1M | ||
| Q2 24 | $25.2M | $-617.0K | ||
| Q1 24 | $25.2M | $160.0K |
| Q4 25 | $23.3M | — | ||
| Q3 25 | $24.0M | — | ||
| Q2 25 | $23.6M | — | ||
| Q1 25 | $24.1M | — | ||
| Q4 24 | $23.4M | $3.4M | ||
| Q3 24 | $26.4M | $3.9M | ||
| Q2 24 | $27.3M | $3.9M | ||
| Q1 24 | $27.8M | $5.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $116.4K | $-1.7M |
| Free Cash FlowOCF − Capex | $24.3K | $-1.7M |
| FCF MarginFCF / Revenue | 0.4% | -35.4% |
| Capex IntensityCapex / Revenue | 1.5% | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-1.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $116.4K | — | ||
| Q3 25 | $638.0K | — | ||
| Q2 25 | $28.2K | — | ||
| Q1 25 | $-2.0M | — | ||
| Q4 24 | $-60.1K | $-1.7M | ||
| Q3 24 | $-58.2K | $-2.4M | ||
| Q2 24 | $363.5K | $-1.4M | ||
| Q1 24 | $-398.8K | $-2.0M |
| Q4 25 | $24.3K | — | ||
| Q3 25 | $492.1K | — | ||
| Q2 25 | $-22.8K | — | ||
| Q1 25 | $-2.1M | — | ||
| Q4 24 | $-118.1K | $-1.7M | ||
| Q3 24 | $-368.9K | — | ||
| Q2 24 | $58.0K | — | ||
| Q1 24 | $-491.8K | $-2.0M |
| Q4 25 | 0.4% | — | ||
| Q3 25 | 6.7% | — | ||
| Q2 25 | -0.3% | — | ||
| Q1 25 | -28.3% | — | ||
| Q4 24 | -2.9% | -35.4% | ||
| Q3 24 | -5.3% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | -6.3% | -75.3% |
| Q4 25 | 1.5% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 1.4% | 0.1% | ||
| Q3 24 | 4.5% | — | ||
| Q2 24 | 3.8% | 0.0% | ||
| Q1 24 | 1.2% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | 9.44× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -5.01× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.56× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CVR
| Fastener | $5.1M | 85% |
| Other | $890.7K | 15% |
NBY
| Other | $2.4M | 51% |
| Total Product Revenue | $2.3M | 49% |
